Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

Harel Insurance Investments & Financial Services Ltd. increased its Teva holding to 6.84% of its reportable U.S. equity ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Stocks to Buy with Exponential Growth Heading into 2026.

Fusen Pharmaceutical Co., Ltd. ( ($HK:1652) ) has shared an update. Fusen Pharmaceutical Co., Ltd. announced that its Metformin Empagliflozin ...

Shandong Xinhua Pharmaceutical Company Limited Class H ( ($HK:0719) ) has provided an announcement. Shandong Xinhua Pharmaceutical Company Limited ...

BioMarin Pharmaceutical (NASDAQ: BMRN) reported its third-quarter earnings after market close Monday, and they were good ...

The company crushed analyst profitability estimates, both for its trailing quarter and for its full-year guidance.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most profitable biotech stocks to buy. Wells Fargo maintained a Buy ...

Gov. Glenn Youngkin announced a landmark partnership Friday with AstraZeneca, Lilly and Merck to create the nation’s largest ...

The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...

In May, President Trump signed an executive order imposing Most-Favored-Nation (MFN) price caps on pharmaceuticals. While the ...

A new article published in the Journal of Medical Internet Research challenges the foundational research model that has ...